Compounds > 2,3-bis(3'-hydroxybenzyl)butyrolactone
Page last updated: 2024-09-02

2,3-bis(3'-hydroxybenzyl)butyrolactone and Cancer of Ovary

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Cancer of Ovary in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Cao, D; Chen, H; Kossinna, P; Li, Q; Lin, C; Lin, J; Liu, GR; Liu, H; Liu, SL; Luo, Y; Wang, J; Wang, P; Wang, X; Wang, Y; Xie, K; Xu, M; Xu, X; Yang, H; Yang, J; Zeng, Z; Zhang, MC; Zhang, XH; Zhu, S1
Bao, HX; Gao, S; Gao, T; Hu, S; Johnston, RN; Li, QH; Li, T; Liu, H; Liu, J; Liu, SL; Liu, Y; Mastriani, E; Qi, Y; Shen, Z; Wang, H; Wang, S; Wang, X; Yu, M; Zeng, Z; Zhou, YJ1
Dikshit, A; Eilati, E; Gao, C; Gomes Filho, MA; Hales, DB; Klug, T; McGee, S; Small, C1

Other Studies

3 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Cancer of Ovary

ArticleYear
Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1.
    Phytotherapy research : PTR, 2023, Volume: 37, Issue:10

    Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Endothelial Cells; Female; Humans; Mice; Ovarian Neoplasms; Thrombospondin 1; Trabectedin; Vascular Endothelial Growth Factor A

2023
Enterolactone has stronger effects than enterodiol on ovarian cancer.
    Journal of ovarian research, 2017, Jul-24, Volume: 10, Issue:1

    Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Survival; Female; Humans; Lignans; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Phytoestrogens; Tumor Burden; Wound Healing

2017
Flaxseed reduces the pro-carcinogenic micro-environment in the ovaries of normal hens by altering the PG and oestrogen pathways in a dose-dependent manner.
    The British journal of nutrition, 2015, May-14, Volume: 113, Issue:9

    Topics: 4-Butyrolactone; Animals; Anticarcinogenic Agents; Chickens; Cyclooxygenase 1; Cyclooxygenase 2; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP3A; Diet; Dietary Supplements; Dinoprostone; Estrogen Receptor alpha; Estrogens; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Female; Flax; Hydroxyestrones; Lignans; Liver; Ovarian Neoplasms; Ovary; RNA, Messenger

2015